Opioid overdose: toxidrome and naloxone decision

It is three in the morning. The rescue team brings in a man of about thirty found in a station bathroom, drowsy, breathing slowly, with pupils that someone in the corridor describes as "very small". On the stretcher, the phrase is already going around: "it's an overdose, give naloxone and that's it". It could be. And it could also be hypoglycemia, a head injury hidden under the hair, a sedative that naloxone does not reverse, or the sum of all of that. What decides the outcome of the next hour is less the vial and more the reasoning of the person standing next to the stretcher.

NEXO is a daily medical diagnosis game: one clinical case a day, up to six progressive clues, and ICD-10 proximity feedback across five levels.

This text treats opioid overdose as a problem of clinical reasoning: recognizing a pattern without getting stuck on it, building the differential for reduced consciousness, deciding on naloxone for the right goal (ventilation, not full awakening) and planning monitoring after the response. The text focuses on the decision and the reasoning; doses and local protocols stay with your service's guideline. Addiction here is the setting. The subject is how you think when the pattern seems obvious.

Key points

• The classic opioid toxidrome combines reduced consciousness, hypoventilation and miosis; hypoventilation is the finding that weighs most in the decision.
• Miosis helps, but it misleads: it may be absent in co-ingestions, prolonged hypoxia and with some opioids, and it appears in other poisonings.
• The goal of naloxone is to restore adequate ventilation. Full and abrupt awakening usually brings withdrawal, agitation and vomiting, with no gain in safety.
• Ventilating with a bag-valve-mask comes before or alongside naloxone when there is apnea or hypoxia; the order of actions is part of the reasoning.
• The response to naloxone is a diagnostic datum, not an endpoint: a partial response forces you to reopen the differential.
• Naloxone lasts less than several opioids; monitoring, reassessment and the conversation before discharge are clinical steps, not bureaucracy.

Why overdose is a problem of reasoning

The World Health Organization describes opioid overdose as one of the leading causes of preventable death among people who use drugs and notes that it is reversible when naloxone and respiratory support are available in time (WHO, Opioid overdose). That reversibility is precisely what makes the moment dangerous for reasoning: when a fast antidote exists, the temptation is to turn the diagnosis into a reflex.

The reflex works most of the time. The problem is the times it does not. A patient with reduced consciousness and small pupils may have taken an opioid and, at the same time, hit their head when falling. They may have used an opioid mixed with a non-opioid sedative. They may have hypoglycemia that produced a similar picture. In all these scenarios, naloxone may improve part of the picture and mask the rest.

The pattern as a shortcut

Recognizing patterns is a legitimate skill. Experienced doctors do it all the time, and the fast reasoning process (the so-called system 1) is what allows action in seconds when seconds matter. The post on heuristics in clinical reasoning shows how these shortcuts work and when they fail. In overdose, the shortcut is useful to start; the error is stopping there.

The risk of error in both directions

There are two symmetrical errors. The first is attributing everything to the opioid and letting another cause slip by. The second is hesitating before a patient in frank hypoventilation because "it could be something else". Good reasoning holds both ideas together: it treats what is likely and dangerous now, and keeps looking for what else may be happening. Reviews on diagnostic error in internal medicine show that cognitive failures such as premature closure appear frequently among the causes of error (Graber et al., 2005).

The opioid toxidrome: the pattern and its limits

A toxidrome is a grouping of signs that suggests a class of substance. The opioid one is classically described by the triad of reduced level of consciousness, respiratory depression and miosis (Boyer, 2012). Each component carries different weight in the decision.

Hypoventilation: the finding that decides

Respiratory depression is what kills and what naloxone treats. That is why it deserves measurement, not impression. Respiratory rate, depth, color, oximetry and, when available, capnography say more than "he is breathing". A patient can have an apparently acceptable rate and very shallow ventilation. The central question is: is this patient ventilating enough right now?

Decreased consciousness: nonspecific by nature

A low level of consciousness appears in dozens of conditions. It confirms severity, but does little to discriminate the cause. Use the Glasgow Coma Scale to record and track the evolution, because the curve over the minutes will be one of the most useful data points after naloxone.

Miosis: useful and treacherous

Pinpoint pupils reinforce the opioid hypothesis. Even so, pharmacological reviews remind us that miosis may be absent when there is co-ingestion of substances with a sympathomimetic or anticholinergic effect, when hypoxia has already produced injury, or with some specific opioids (Kim and Nelson, 2015). And small pupils appear in other situations, such as some brainstem lesions and poisonings by other classes. Miosis raises the probability; it does not close the case.

Context as a clue, with care

Objects found with the patient, witness accounts and prior history count as clues. The care is in remembering that context raises the pre-test probability without eliminating the rest. The post on pre-test probability shows how a strong clue changes the starting point, not the destination. A syringe next to the patient makes opioid more likely; it does not rule out trauma from the fall.

The differential of decreased consciousness that cannot be missed

Building the differential does not delay treatment when it is done in parallel. While one person ventilates and prepares naloxone, another measures capillary glucose and examines the head. The differential below is not a list to memorize; it is the list of what changes management if you let it slip by.

Metabolic causes

• Hypoglycemia: cheap to measure, quick to correct and capable of mimicking almost any decreased consciousness.
• Hypercapnia from another cause, such as advanced lung disease, which also depresses consciousness.
• Severe electrolyte disturbances and metabolic encephalopathies, more likely in those with an underlying disease.

Structural and neurological causes

Traumatic brain injury from the fall can coexist with intoxication. Stroke, especially brainstem stroke, alters pupils and breathing at the same time. And postictal state or a seizure without visible convulsion enter the list when consciousness does not improve as expected.

Other poisonings and co-ingestions

Hypnotic sedatives, alcohol and other depressant substances add to the opioid effect and do not respond to naloxone. The review on serotonin syndrome in the emergency department shows, by contrast, how a different toxidrome presents with its own clues, such as hyperthermia and clonus, and why recognizing the wrong pattern leads to the wrong management (Morarasu et al., 2022). The lesson for overdose is the same: each toxidrome has clues that confirm it and clues that contradict it.

Infection and other systemic causes

Sepsis, meningitis and endocarditis appear more often in people who inject drugs and can decrease consciousness. Fever, a new murmur or neck stiffness are clues that change the direction of the case.

The naloxone decision: goal, route and titration

Naloxone is a competitive opioid receptor antagonist. It displaces the opioid and restores ventilation, but it can also precipitate acute withdrawal in those with physical dependence (Boyer, 2012). This double face is why the decision has nuance.

First, the goal

The target is adequate ventilation, not an awake and talking patient. Reviews on naloxone dosing support titrating until respiratory improvement and remind us that high starting doses increase the risk of precipitated withdrawal, agitation, vomiting and aspiration (Rzasa Lynn and Galinkin, 2018). A patient who is breathing well again, still drowsy, is in the right place.

Ventilation before and alongside

If the patient is in apnea or has severe hypoxia, ventilating with a bag-valve-mask and oxygen is the immediate action. Naloxone comes along with it, not in its place. The sequence matters because prolonged hypoxia causes damage on its own and because oxygenating before reversing reduces the risk of complications when the patient wakes up.

Route and context

The route depends on the setting: intravenous when there is access and monitoring, intramuscular or intranasal in the community and in pre-hospital care. The WHO guidance for community management recommends that people likely to witness an overdose have access to naloxone and know how to use it (WHO, Community management of opioid overdose). For the student, the reasoning point is that the route changes the speed of onset and the ease of titrating, and that changes how you reassess.

Potent synthetic opioids

With high-potency synthetic opioids, such as fentanyl derivatives, onset is fast and repeated doses may be needed. NIDA gathers the information on harm reduction and reminds us that naloxone remains the basis of the response to overdose in these settings (NIDA, 2022). The reasoning here is titration with frequent reassessment, not a fixed dose.

The response as diagnostic data

After each dose, ask: what improved and what did not improve? Ventilation that normalizes while consciousness stays low suggests another cause on top, such as a sedative, trauma or hypoglycemia. No response with adequate doses forces you to reopen the whole differential. The partial response is one of the most informative clues in the case and is often the most ignored.

A fictional case, minute by minute

Go back to the man at the station. In the first minute, the team measures a low respiratory rate, falling oximetry and small pupils. Someone starts ventilating with a bag-valve-mask and oxygen. Another person measures the capillary glucose, which comes back normal, and runs a hand over the scalp: there is a hematoma in the occipital region. This clue does not change the first action, but it changes what you will look for later.

In the third minute, naloxone goes in at a low dose, with reassessment right after. Ventilation improves, oximetry rises, and the patient starts responding to being called with mumbling. The team resists the temptation to repeat the dose until he is fully awake. The goal was reached: adequate ventilation.

In the tenth minute, ventilation is good, but consciousness did not follow as expected. He opens his eyes, but is confused about the place and cannot sustain attention. Here is the fork in the case. A hasty reading would say "it is the drug still". A careful reading puts three clues together: the hematoma, the complete respiratory response and the incomplete neurological response. The hypothesis of associated head trauma rises, and imaging investigation enters the conversation.

In the thirtieth minute, the patient is more alert and says he also took a sleeping pill that an acquaintance offered him. This information explains part of the drowsiness that naloxone did not reverse and reinforces the need for longer observation than in a simple case. The case, which arrived with a label, ends with three hypotheses worked in parallel, each with its clue.

Notice that none of these decisions depended on knowing a dose table by heart. It depended on asking, at each response, what improved, what did not improve and what that means. This is the reasoning that the overdose scenario trains better than almost any other: acting fast without stopping thinking.

After the response: resedation, observation and discharge

Naloxone has a shorter duration of action than many opioids, especially long-acting ones and extended-release formulations. This creates the risk of resedation when the antagonist loses effect (Kim and Nelson, 2015).

How long to observe

A systematic review of patients reversed after heroin overdose concluded that the risk of death from rebound toxicity is very low in the absence of co-intoxicants and of further use, and that in the emergency department one hour of observation may be enough when the patient walks as usual, has normal vital signs and full consciousness (Willman et al., 2017). A prospective one-hour clinical assessment rule was validated to stratify who can be discharged after one hour (Clemency et al., 2019). The reasoning is that of any decision rule: it helps to stratify, and the exceptions (long-acting opioid, co-ingestion, comorbidity) call for more time.

What to reassess before discharge

• Consciousness, ventilation and oximetry at rest and after walking.
• Signs of associated injury, such as trauma, aspiration or compression injury.
• Likely substance and its expected duration.
• Presence of co-ingestion suggested by the history or by an incomplete response.
• Support network and access to naloxone for the coming days.

The conversation that is part of treatment

Discharge after an overdose is a high-risk clinical moment and also an opportunity. Cohorts show that receiving medication treatment for opioid use disorder after a nonfatal overdose is associated with lower mortality in the following year (Larochelle et al., 2018). Offering take-home naloxone, explaining warning signs and asking whether the person wants to talk about treatment is part of the care reasoning, not an appendix. When there is immediate risk, seek the necessary help with the team and local services.

Biases that show up on the stretcher

The overdose setting brings together conditions that favor cognitive errors: haste, a noisy environment, labels that arrive before the patient and strong emotions in the team. A classic review of cognitive errors in diagnosis describes these mechanisms and strategies to reduce them (Croskerry, 2003).

Anchoring and premature closure

The first hypothesis, "it is an overdose", becomes the anchor. Everything that follows is read to confirm it. The diagnostic pause is the cognitive antidote: after the first response to naloxone, stop for a few seconds and ask "what else could explain what I am seeing?".

Affective bias and stigma

People who use drugs trigger reactions in the team, ranging from impatience to moral judgment. A randomized study showed that professionals exposed to the term "substance abuser" assigned more blame and defended more punitive measures than those exposed to "person with a substance use disorder" (Kelly and Westerhoff, 2010). The post on affective bias goes deeper into how emotion enters diagnosis. On the stretcher, it enters as haste to "sort it out and release" and as less willingness to look for another cause. NIDA gathers evidence that stigma keeps people away from care and worsens outcomes (NIDA, Stigma and Discrimination). The series covers language and stigma in its own post, on how the label changes conduct.

Confirmation bias after the response

When naloxone works, the team tends to consider the case resolved. A good response confirms the opioid; it does not rule out the second cause. Diagnostic checklists have been proposed exactly for this moment of false safety (Ely et al., 2011).

Reviews of biases in medical decisions

A systematic review found an association between cognitive biases and management errors in different clinical settings, including overconfidence and anchoring (Saposnik et al., 2016). The overdose setting is no exception; it is one of the best examples for training recognition of these biases.

Table: clue, what it suggests and what can mislead

Clue	What it suggests	What can mislead
Hypoventilation with reduced consciousness	Probable opioid toxidrome	Sedatives and hypercapnia from another cause produce a similar picture
Miosis	Reinforces the opioid hypothesis	May be absent in co-ingestion and hypoxia; appears in brainstem injury
Reported context of use	Increases pre-test probability	Leaves trauma, hypoglycemia or infection open
Good ventilatory response to naloxone	Opioid component confirmed	Consciousness that does not improve suggests a second cause
Absence of response	Reopen the differential	Insufficient dose with a potent opioid also explains it
Rapid improvement and a request for discharge	Candidate for one-hour risk stratification	A long-acting opioid or co-ingestion calls for longer observation
Agitation and vomiting after the dose	Precipitated withdrawal likely	It can mask residual hypoxia or another poisoning

How NEXO helps train this reasoning

NEXO presents fictional cases with a realistic clinical presentation and up to six progressive clues. This format fits the reasoning of overdose: each new clue forces you to ask whether it confirms the current hypothesis or calls for another one. In cases of reduced consciousness, training the habit of naming the differential before each new clue is a direct exercise against premature closure.

The proximity feedback shows how close your guess came to the target diagnosis. This helps you notice when you got the general category right and missed the detail that changes management. To understand the game, see what NEXO is and the About NEXO page. Usage limits are on the Economy page.

For study groups and academic leagues, NEXO Closer lets you play and discuss as a group. For research, curation and content creation, there are NEXO Researcher, NEXO Curator and NEXO Creators. The post on training the differential with clues shows how to turn each case into a differential exercise, and all the texts are on the Blog.

An exercise for after the case

After playing an emergency case, write three lines: the hypothesis you formed on the first clue, the clue that most changed your probability, and the cause you would have missed if you had stopped at the first hypothesis. This short record is the same mental exercise that protects the patient from the stretcher at three in the morning.

Frequently asked questions

Can naloxone be given to any patient with reduced consciousness without a diagnosis?

With reasonable suspicion of opioid use and hypoventilation, naloxone is safe and delay is dangerous. The decision must come together with ventilation and the search for other causes. In people with physical dependence, high initial doses precipitate withdrawal, so titration is preferred (Rzasa Lynn and Galinkin, 2018).

Does a normal pupil rule out opioid overdose?

It does not. Miosis is common, but it can be absent in co-ingestions, prolonged hypoxia and with some opioids (Kim and Nelson, 2015). Hypoventilation weighs more in the decision than the pupil.

Why not wake the patient completely?

The goal is adequate ventilation. Abrupt reversal brings withdrawal, agitation, vomiting and risk of aspiration, and it makes the patient want to leave before the necessary observation (Boyer, 2012).

How long should you observe after the response?

It depends on the substance, the co-ingestions and the course. A review and a validated rule support that one hour may be enough in selected cases with a normal exam, and that long-acting opioids call for more time (Willman et al., 2017; Clemency et al., 2019).

What should you do if there is no response to naloxone?

Maintain ventilation and oxygenation, check the dose and the route, and reopen the differential: hypoglycemia, trauma, sedatives, structural causes and infection. Absence of response is diagnostic information.

How should you talk with the patient after reversal?

With non-stigmatizing language, explaining what happened, offering naloxone to take home and asking whether they want to talk about treatment. The series covers motivational interviewing in its own post, for students and residents.

Does this topic show up on exams?

Toxidromes and the decision to use an antidote appear often in emergency and pharmacology vignettes. The reasoning tested is usually recognizing the pattern and the clue that contradicts it.

Final checklist

• I measured ventilation, not just respiratory rate.
• I ventilated with a bag-valve-mask when there was apnea or hypoxia.
• I measured blood glucose and examined the head in parallel.
• I defined the goal of naloxone as adequate ventilation.
• I titrated and reassessed after each dose.
• I read a partial response as a clue to a second cause.
• I considered the duration of the likely opioid before discharge.
• I used non-stigmatizing language and offered naloxone and a conversation about treatment.

Play the case of the day on NEXO and, before each new clue, say out loud which cause you have not ruled out yet.

References

1. World Health Organization. Opioid overdose. Fact sheet. who.int
2. World Health Organization. Community management of opioid overdose. 2014. who.int
3. Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012. PMID: 22784117
4. Kim HK, Nelson LS. Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opin Drug Saf. 2015. PMID: 25865597
5. Rzasa Lynn R, Galinkin JL. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf. 2018. PMID: 29318006
6. Willman MW, et al. Do heroin overdose patients require observation after receiving naloxone? Clin Toxicol (Phila). 2017. PMID: 27849133
7. Clemency BM, et al. Hospital Observation Upon Reversal (HOUR) with naloxone: a prospective clinical prediction rule validation study. Acad Emerg Med. 2019. PMID: 30592101
8. Morarasu BC, et al. Recognition and management of serotonin toxidrome in the emergency department: case based review. J Pers Med. 2022. PMID: 36556289
9. Larochelle MR, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018. PMID: 29913516
10. Graber ML, Franklin N, Gordon R. Diagnostic error in internal medicine. Arch Intern Med. 2005. PMID: 16009864
11. Croskerry P. The importance of cognitive errors in diagnosis and strategies to minimize them. Acad Med. 2003. PMID: 12915363
12. Ely JW, Graber ML, Croskerry P. Checklists to reduce diagnostic errors. Acad Med. 2011. PMID: 21248608
13. Saposnik G, et al. Cognitive biases associated with medical decisions: a systematic review. BMC Med Inform Decis Mak. 2016. PMID: 27809908
14. Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010. PMID: 20005692
15. Volkow ND. NIH Invests in a New Harm Reduction Research Network. National Institute on Drug Abuse, Nora's Blog, Dec. 16, 2022. nida.nih.gov
16. National Institute on Drug Abuse. Stigma and Discrimination. nida.nih.gov